? Join hands with capital to create a new global agrochemical landscape

Jiangxi Zhonghe Group has Zhonghe Biotechnology Co., Ltd. and Zhonghe Chemical Co., Ltd. under its wing, forming a complete industrial chain layout from the research and development and production of raw materials to the development and sales of preparations. We focus on the development of green and efficient patented pesticide products and are committed to entering the global market through compliant registration.

Under the backdrop of the "dual carbon strategy" and green agriculture, Zhonghe is rapidly growing into an agrochemical manufacturing enterprise with international potential by leveraging its technological barriers, registration capabilities, and complete supply chain advantages. We welcome industrial investors and strategic partners to join hands with us for development and jointly plan the future agrochemical industry.

? Technical Material Section | Zhonghe Biotechnology Co., LTD

Focusing on the development of cyclic flavonoid active pharmaceutical ingredients, the current core products include:

● Cyclosulfonone (expected to obtain the GLP registration report by the end of 2025)

● Ding Xilong (GLP Registration Report Completed)

● Azoxacinone, benzooxacinone, cyclosulfonone acid (Continuously advancing the process and registration preparation)

We have a complete quality control system and registration support capabilities, and are actively connecting with global registration cooperation.

? Formulation Division | Zhonghe Chemical Co., LTD

We have developed over a hundred types of formulation products, covering a wide range of herbicide, fungicide and insecticide formulations, and possess stable production capacity and export compliance experience.

The registration and layout work for overseas markets has been officially launched. In the future, sales networks will be gradually established in markets such as Southeast Asia and Latin America.

? Four major advantages

● Dual-wheel drive of R&D and registration: The original drug product is innovative and has GLP support capabilities, facilitating global registration

● Upstream and downstream integration: The coordinated development of active pharmaceutical ingredients and preparations to form a cost advantage in synergy

● Globalization potential: Actively layout the international market, and the products have the space for substitution and growth

● Cooperation and openness: We welcome capital providers, registered partners, and channel partners to engage in various forms of strategic cooperation

? Investors can obtain

● Enterprise and product introduction

● GLP Registration Progress and Overseas Market planning

● Factory qualifications and production capacity

● Investment cooperation model and connection process